Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study
PHASE4CompletedINTERVENTIONAL
Enrollment
8
Participants
Timeline
Start Date
August 31, 2014
Primary Completion Date
June 30, 2016
Study Completion Date
July 31, 2016
Conditions
Diabetes
Interventions
DRUG
Gliclazide
DRUG
Glibenclamide
Trial Locations (1)
768828
Khoo Teck Puat Hospital, Singapore
All Listed Sponsors
lead
Khoo Teck Puat Hospital
OTHER
NCT02201602 - Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study | Biotech Hunter | Biotech Hunter